(Q37917053)

25 August 2017

title

Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection (English)

1 reference

25 August 2017

Robert E Elliott

1

1 reference

25 August 2017

Erik C Parker

2

1 reference

25 August 2017

Stephen C Rush

3

1 reference

25 August 2017

Stephen P Kalhorn

4

1 reference

25 August 2017

Yaron A Moshel

5

1 reference

25 August 2017

Ashwatha Narayana

6

1 reference

25 August 2017

Bernadine Donahue

7

1 reference

25 August 2017

John G Golfinos

8

1 reference

25 August 2017

publication date

1 July 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

76

1 reference

25 August 2017

issue

1-2

1 reference

25 August 2017

page(s)

128-40; discussion 61-2

1 reference

Reoperation in the treatment of recurrent intracranial malignant gliomas

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

'Recurrent' glioblastoma multiforme, when should we reoperate?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Survival and functional status after resection of recurrent glioblastoma multiforme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Stereotactic radiosurgery for glioblastoma: retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Bevacizumab: a treatment option for recurrent glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Diagnosis and treatment of recurrent high-grade astrocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Stereotactic radiosurgery for recurrent malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Salvage therapy in patients with glioblastoma: is there any benefit?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Gamma knife for glioma: selection factors and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Reirradiation tolerance of the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Stereotactic radiosurgery and interstitial brachytherapy for glial neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

A comparison of treatment results for recurrent malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Long-term survival in patients with malignant astrocytoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Glioma extent of resection and its impact on patient outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

The radiosurgery of glioblastoma multiforme in cases of recurrence. The Heidelberg experiences compared to the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Reirradiation of primary brain tumours: survival, clinical response and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.12.053

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.WNEU.2010.12.053

1 reference

25 August 2017

1 reference